FREQUENCY OF OCCURRENCE OF CHRONIC VIRAL HEPATITIS AMONG THE POPULATION OF THE REPUBLIC OF AZERBAIJAN ACCORDING TO THE DATA ON CIRCULATION

Authors:

Abstract:

1,611 people who applied to the medical center “Medikus Clinic” in Baku were examined, 836 of them were men and 775 women. Verification of viral hepatitis B and viral hepatitis C was carried out based on the determination of the hepatitis B virus surface antigen using enzyme immunoassay and hepatitis C virus by polymerase chain reaction on the immunochemical analyzer Beckman Coulter Unicel DXi 800. Of the total number of examined patients, hepatitis B was detected in 642 patients (39.85 %), of which 24.8 % were men and 15.02 % were women. The analysis of the data revealed a high incidence of the disease in people under 40 years of age with a sharp decrease in the indicator after 40 years and a minimum value after 60. In patients with hepatitis C without regional differences, an increase in the incidence of the disease was detected in the age range from 30 to 60 years. In the 60≤ group, there was a decline in the disease in men. It was found that the patients were mainly concentrated in Baku, then in the regions of Azerbaijan and in Sumgait. Unlike age, the male sex has always retained its importance as a risk factor. Chronic types of viral hepatitis B and viral hepatitis C were more common in people of working age.

Keywords:

chronic hepatitis B chronic hepatitis C age dynamics men women

References:

1. Antonova TV, Romanova MA. Khronicheskaya HCV–infektsiya i insulinorezistentnost. Effektivnaya farmakoterapiya. Gastroenterologiya. 2017; 2:1–8 [in Russian]
2. Biryukova YeV, Rodionova SV. Sakharnyy diabet 2-go tipa i nealkogolnaya zhirovaya bolezn pecheni. Meditsinskiy almanakh. 2017; 5(3): 130–134 [in Russian]
3. Kravchenko LA. Vyvchennia osoblyvostei іmunnogo statusu patsіyentіv іz poyednanum perebіhom khronіchnoho vіrusnoho hepatytu C ta vіrusu іmunodefіtsytu liudyny. Svit medytsyny ta biolohii. 2017; 2(60): 70–75. [in Russian]
4. Krolevets TS, Livzan MA. Nealkogolnaya zhirovaya bolezn pecheni: daydzhest 2021. Dokazatelnaya gastroenterologiya. 2021;10(2):27–35. https://doi.org/10.17116/dokgastro20211002127 [in Russian]
5. Kurminova GM, Akimova NA. Sakharnyy diabet u bolnykh khronicheskim virusnymi gepatitom B i C. Medicine (Almaty). 2017; 9(183):123–128. [in Russian]
6. Morgunov LYu. Sakharnyy diabet u patsiyentov s tsirrozom pecheni: novyye vozmozhnosti lecheniya. Issledovaniya i praktika v meditsine. 2017; 4 (3): 75 DOI: 10.17709/2409-2231-2017-4-3-7 [in Russian]
7. Tsvetkov VV, Tokin II, Pozdnyakova SA. Klinicheskaya epidemiologiya vnepechenochnykh proyavleniy khronicheskoy infektsiyey vyzvannoy virusom gepatita S. Meditsinskiy Sovet. 2019;(21):248–253. doi.10.21518/2079-701X-2019-21-248-253 [in Russian]
8. Eyvazov T. Analiz zabolevaemosti virusnymi gepatitami v period s 1990 po 2003 gg. v Azerbaydzhanskoy Respublike. Azerbaydzhanskiy meditsinskiy zhurnal. 2007; 2: 28–31. [in Russian]
9. Badawi MM, Atif MS, Mustafa YY. Systematic review and meta-analysis of HIV, HBV and HCV infection prevalence in Sudan. Virol J. 2018 Sep 25;15(1):148. doi: 10.1186/s12985-018-1060-1.
10. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. Global strategy. Geneva WHO/HIV/2016.06
11. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. European Union HCV Collaborators. Lancet Gastroenterol Hepatol. 2017 May;2(5):325–336. doi: 10.1016/S2468-1253(17)30045-6.
12. Lim AG, Qureshi H, Mahmood H, Hamid S, Davies CF, Trickey A, et al. Curbing the hepatitis C virus epidemic in Pakistan: The impact of scaling up treatment and prevention for achieving elimination. International Journal of Epidemiology, 2018; 47(2), 550–560.
13. Lingani M, Akita T, Ouoba S, Sanou AM, Sugiyama A, Tarnagda Z, et al. High prevalence of hepatitis B infections in Burkina Faso (1996-2017): a systematic review with meta-analysis of epidemiological studies. BMC Public Health. 2018 Apr 25;18(1):551. doi: 10.1186/s12889-018-5432-7.
14. Pavlovskyi SA, Virstyuk NG. Determination of fiber development of liver in patients with type 2 diabetes mellitus associated with non-alcohol fatty liver disease. World of Medicine and Biology 2018; 1(63) : 061–064 DOI 10.26724/2079-8334-2018-1-63-61-64
15. Stepanov YuM, Nedzvetskaya NV, Yagmur VB, Klenina IIA, Oshmyanskaya NYu.. Noninvasive diagnosis of liver fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology, 2017; 51(3): 188–195. doi.org/10.22141/2308-2097.51.3.2017.112635

Publication:

«World of Medicine and Biology» Vol. 19 No. 84 (2023) , с. 153-157
УДК 116. 36.002-08

DOI:

https://doi.org/10.26724/2079-8334-2023-2-84-153-157